{"id":"NCT01597908","sponsor":"Novartis Pharmaceuticals","briefTitle":"Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma","officialTitle":"A Phase III, Randomised, Open-label Study Comparing the Combination of the BRAF Inhibitor, Dabrafenib and the MEK Inhibitor, Trametinib to the BRAF Inhibitor Vemurafenib in Subjects With Unresectable (Stage IIIc) or Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06-04","primaryCompletion":"2014-04-17","completion":"2019-04-25","firstPosted":"2012-05-14","resultsPosted":"2014-12-04","lastUpdate":"2021-02-24"},"enrollment":704,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Melanoma"],"interventions":[{"type":"DRUG","name":"Dabrafenib","otherNames":["GSK2118436"]},{"type":"DRUG","name":"Vemurafenib","otherNames":["Monotherapy"]},{"type":"DRUG","name":"Trametinib","otherNames":["GSK1120212"]}],"arms":[{"label":"Dabrafenib plus Trametinib","type":"EXPERIMENTAL"},{"label":"Vemurafenib","type":"ACTIVE_COMPARATOR"}],"summary":"This was a two-arm, open-label, randomized, Phase III study comparing dabrafenib (GSK2118436) and trametinib (GSK1120212) combination therapy with vemurafenib.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From the date of randomization until date of death due to any cause (up to approximately 6 years)","effectByArm":[{"arm":"Dabrafenib Plus Trametinib","deltaMin":26,"sd":null},{"arm":"Vemurafenib","deltaMin":17.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":205,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Czechia","Denmark","Finland","France","Germany","Hungary","Ireland","Israel","Italy","Netherlands","New Zealand","Norway","Poland","Russia","South Korea","Spain","Sweden","Switzerland","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["34225229","31166680","27864013","26433819","25399551"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":172,"n":350},"commonTop":["Arthralgia","Diarrhoea","Pyrexia","Nausea","Rash"]}}